Remsima 40 mg/mL concentrate for solution for infusion (100mg & 350mg vials)
*Company:
Celltrion Healthcare Ireland Ltd.Status:
NewLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
File name
CT-P13(Liq)_PAC(IE)_final.pdf
Reasons for updating
- Add New Doc
File name
Remsima (infliximab)-new-iv-formulation--direct-healthcare-professional-communication.pdf
Reasons for updating
- Add New Doc
Updated on 01 April 2026
File name
SmPC_Remsima Liquid 100mg & 350mg vial_en_Dec 2025.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 April 2026
File name
CT-P13(Liq) 350mg_Leaflet(IE)_ver2(CLT).pdf
Reasons for updating
- New PIL for new product
Updated on 01 April 2026
File name
CT-P13(Liq) 100mg_Leaflet(IE)_ver2(CLT).pdf
Reasons for updating
- New PIL for new product
Celltrion Healthcare Ireland Ltd.
Address:
26 Arrow Building, Old Belgard Road, Tallaght, Dublin, D24 ND70Medical Information E-mail:
Medinfoie@celltrionhc.comTelephone:
01 223 4026